Cyclodextrins (CDs) are enabling pharmaceutical excipients that can enhance both
solubility and stability of wide variety of drugs in aqueous solutions through formation of …

In most cancer treatments, chemotherapy is currently necessary; hence, more attention was
devoted to developing new methods for designing drug delivery systems (DDS) with …

Nanoparticles (NPs) for targeted therapy are required to have appropriate size, stability,
drug loading and release profiles, and efficient targeting ligands. However, many of the …

Poor availability in deep-seated solid tumors is a significant challenge that limits the
effectiveness of currently used anticancer drugs. Approaches that can specifically enhance …

Modification of drug delivery materials with beta‐cyclodextrins (β‐CyD) is known to increase
solubility of poorly water‐soluble drugs, protect drugs from degradation and sustain release …

Lung cancer is often diagnosed at an advanced stage where tumors are usually inoperable
and first-line therapies are inefficient and have off-targeted adverse effects, resulting in poor …

Patients with advanced ovarian cancer develop recurrence despite initial treatment
response to standard treatment of surgery and intravenous/intraperitoneal (IP) …

Paclitaxel-loaded poly (lactic acid-co-glycolic acid)(PLGA) microspheres containing different
portions of human serum albumin microparticles (mHSA) were prepared via an in situ …

Nanoparticles (NPs) have shown significant potential for pulmonary administration of
therapeutics for the treatment of chronic lung diseases in a localized and sustained manner …

In this study, poly (d, l-lactide-co-glycolide), PLGA, was developed as an in situ forming
implants (ISFIs) to improve the therapeutic efficiency and to devoid the adverse effects of the …